Hims & Hers Health Inc (XSWX:HIMS)
CHF 29.89 (0%) Market Cap: 6.89 Bil Enterprise Value: 7.20 Bil PE Ratio: 0 PB Ratio: 18.66 GF Score: 81/100

Q1 2026 Hims & Hers Health Inc Earnings Call Transcript

May 11, 2026 / 09:00PM GMT

Key Points

Positve
  • Hims & Hers Health Inc (HIMS) reported a strong start to 2026 with significant progress on strategic objectives, reinforcing confidence in their 2030 targets.
  • The company is expanding its global scale, which is becoming a competitive advantage by increasing its total addressable market and strengthening partnerships.
  • Hims & Hers Health Inc (HIMS) is deepening customer relationships by addressing gaps in traditional care systems with proactive care offerings.
  • Investments in data and technology infrastructure are creating a more agile platform, enabling faster geographic and product expansion.
  • The strategic shift in the weight loss business to prioritize branded products is expected to expand the addressable market significantly, with early success signals emerging.
Negative
  • The strategic pivot in the weight loss specialty resulted in approximately $33 million of restructuring costs, impacting financials in the first quarter.
  • Revenue and adjusted EBITDA within US operations were temporarily pressured by revenue recognition dynamics and a tougher comparable period.
  • The company expects gross margins to compress as they prioritize scaling areas such as weight loss, labs, and international markets, which have a lower gross margin profile.
  • GAAP net income declined to a loss of $92 million in Q1, impacted by nonrecurring restructuring costs, transaction costs related to M&A activity, and legal costs.
  • There is expected volatility in GAAP financial margins as the company continues to invest in strategic opportunities, which may impact short-term financial results.
Operator

Hello, and thank you for standing by. My name is Tiffany, and I will be your conference operator today. At this time, I would like to welcome everyone to the Hims & Hers first quarter 2026 earnings call. (Operator Instructions)

I would now like to turn the call over to Bill Newby, Head of Investor Relations. Bill, please go ahead.

Bill Newby
Hims & Hers Health Inc - Head of Investor Relations

Good afternoon, everyone, and welcome to the Hims & Hers Health first quarter 2026 earnings call. Before we dive in, I want to provide an update on our approach to earnings communications. Moving forward, the company is transitioning to publishing an annual shareholder letter, and we'll continue to provide regular updates through our quarterly earnings call, earnings release and supplemental materials.

We believe this approach will enable our shareholder letter to reflect the long-term nature of our strategy and focus on the sustained value we're building. On the call with me today is Andrew Dudum, our Co-Founder and Chief Executive Officer

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot